Skip to main content
Earnings Labs
Aclaris Therapeutics, Inc. logo

Aclaris Therapeutics, Inc. (ACRS)

NASDAQ·Healthcare·Biotechnology

$4.45

+2.53%

Mkt Cap $520.97M

Analyst Ratings

Buy

6

Hold

0

Sell

0

Price Target (9 analysts)

$10.60

Range $10.00$12.00

Implied Upside

+138.2%

Consensus $10.60 vs current $4.45